Chugai Pharm ADR (CHGCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2024 | 09-2023 | 03-2023 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Other Working Capital | 295,524 | 813,358 | 943,874 | 111,946 | 170,201 |
| Other Operating Activity | 380,594 | 1,158,075 | 27,010 | 1,840,082 | 1,723,437 |
| Operating Cash Flow | $676,117 | $1,971,433 | $970,885 | $1,952,028 | $1,893,638 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -137,464 | -33,334 | -186,535 | -473,515 | -209,463 |
| PPE Investments | -83,562 | -359,918 | -193,747 | -356,623 | -326,827 |
| Purchase Of Investment | -335 | -1,766 | -1,588 | -2,210 | -2,041 |
| Purchase Sale Intangibles | -415 | 91,563 | 112,108 | -61,704 | -51,706 |
| Other Investing Activity | 5,327 | 98,774 | 113,050 | -60,300 | -50,928 |
| Investing Cash Flow | $-216,035 | $-296,245 | $-268,820 | $-892,649 | $-589,258 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -435,232 | -905,459 | -496,782 | -992,146 | -583,206 |
| Other Financing Activity | -12,810 | -40,055 | -14,554 | -39,513 | -27,458 |
| Financing Cash Flow | $-448,042 | $-945,514 | $-511,336 | $-1,031,659 | $-610,664 |
| Exchange Rate Effect | 16,020 | 23,612 | 3,207 | 17,575 | 18,981 |
| Beginning Cash Position | 3,073,116 | 1,532,966 | 1,688,484 | 1,927,822 | 2,061,698 |
| End Cash Position | 3,101,182 | 2,286,253 | 1,882,414 | 1,973,110 | 2,774,395 |
| Net Cash Flow | $28,066 | $753,287 | $193,929 | $45,295 | $712,697 |
| Free Cash Flow | |||||
| Operating Cash Flow | 676,117 | 1,971,433 | 970,885 | 1,952,028 | 1,893,638 |
| Capital Expenditure | -82,926 | -373,635 | -206,636 | -364,766 | -335,720 |
| Free Cash Flow | 593,191 | 1,597,798 | 764,248 | 1,587,262 | 1,557,918 |